Nyxoah (NYXH) Research & Development (2021 - 2026)
Nyxoah's (NYXH) quarterly Research & Development came in at -$10307.2 in Q1 2026, down 9.01% year-on-year from -$11327.8 in Q1 2025, and down 100.0% quarter-over-quarter from $12.6 billion in Q4 2025.
Nyxoah (NYXH) Research & Development (2021 - 2026) Analysis & Trends
Nyxoah's Research & Development history runs 6 years deep, the most recent figure standing at -$10307.2 for Q1 2026.
- On a quarterly basis, Research & Development fell 9.01% year-over-year to -$10307.2 in Q1 2026; TTM through Mar 2026 was $12.6 billion, a 200.37% increase from a year earlier, with the FY2025 full-year figure at $49.8 million, up 35.9% from the prior year.
- Research & Development eased to -$10307.2 in Q1 2026 per NYXH's latest filing, from $12.6 billion in the prior quarter.
- Across five years, Research & Development topped out at $12.6 billion in Q4 2025 and bottomed at -$12.6 billion in Q4 2024.
- The 5-year median for Research & Development is -$8.0 million (2024), against an average of -$1.6 billion.
- Across the five-year window, Research & Development plunged 163689.01% in 2023 and soared 200.71% in 2025, its largest moves.
- Year by year, Research & Development stood at -$4.7 billion in 2022, then plunged by 68.76% to -$7.9 billion in 2023, then plunged by 59.43% to -$12.6 billion in 2024, then surged by 200.71% to $12.6 billion in 2025, then plunged by 100.0% to -$10307.2 in 2026.
- Per Business Quant, the three latest NYXH Research & Development figures stand at -$10307.2 (Q1 2026), $12.6 billion (Q4 2025), and -$15.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | -10,307.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,307.24 |
| Dec 31, 2025 | 12.65 Bn |
| Sep 30, 2025 | -15.09 Mn |
| Jun 30, 2025 | -11.39 Mn |
| Mar 31, 2025 | -9,455.39 |
| Dec 31, 2024 | -12.56 Bn |
| Sep 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -8.05 Mn |
| Mar 31, 2024 | -7.82 Bn |
| Dec 31, 2023 | -7.88 Bn |
| Sep 30, 2023 | -7.15 Mn |
| Jun 30, 2023 | -7.19 Mn |
| Mar 31, 2023 | -6.61 Bn |
| Dec 31, 2022 | -4.67 Bn |
| Sep 30, 2022 | -4.26 Mn |
| Jun 30, 2022 | -3.70 Mn |
| Mar 31, 2022 | -4.03 Mn |
| Dec 31, 2021 | -3.82 Bn |
| Sep 30, 2021 | -4.15 Mn |
| Jun 30, 2021 | 3.73 Mn |